Firefly Neuroscience, Inc. (AIFF)
NASDAQ: AIFF · Real-Time Price · USD
2.930
-0.050 (-1.68%)
Nov 21, 2024, 4:00 PM EST - Market closed

Company Description

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders.

The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.

It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

Firefly Neuroscience, Inc.
Firefly Neuroscience logo
Country Canada
Founded 2006
Industry Software - Application
Sector Technology
CEO Jon Olsen

Contact Details

Address:
150 King St W, Suite 722
Toronto, ON M5H 1J9
Canada
Phone 888-237-6412
Website fireflyneuro.com

Stock Details

Ticker Symbol AIFF
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000803578
ISIN Number US3179701012
Employer ID 54-1167364
SIC Code 7372

Key Executives

Name Position
Jon Olsen Chief Executive Officer and Director
Gil Issachar Chief Technology Officer
David Ian Johnson Executive Chairman
Dr. Jason DuBraski Vice President of Sales
Dr. Samer E. Kaba M.D. Chief Medical Officer

Latest SEC Filings

Date Type Title
Nov 15, 2024 8-K Current Report
Nov 14, 2024 10-Q Quarterly Report
Nov 1, 2024 8-K Current Report
Sep 27, 2024 S-1 General form for registration of securities under the Securities Act of 1933
Sep 19, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Sep 16, 2024 8-K/A [Amend] Current report
Aug 21, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Aug 21, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Aug 20, 2024 8-K Current Report
Aug 19, 2024 10-Q Quarterly Report